Black PC - Search Results

1

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Zargar H, et al. Among authors: black pc. Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23. Eur Urol. 2015. PMID: 25257030 Free PMC article.

2

Cystoenteric conversion and reduction cystoplasty for treatment of bladder dysfunction after pancreas transplantation.

Black PC, Plaskon LA, Miller J, Bakthavatsalam R, Kuhr CS, Marsh CL. Black PC, et al. J Urol. 2003 Nov;170(5):1913-7. doi: 10.1097/01.ju.0000091280.96590.a1. J Urol. 2003. PMID: 14532806

3

Extensive palliative surgery for advanced mesothelioma of the tunica vaginalis.

Black PC, Lange PH, Takayama TK. Black PC, et al. Urology. 2003 Oct;62(4):748. doi: 10.1016/s0090-4295(03)00673-3. Urology. 2003. PMID: 14550461

4

Cystoprostatectomy and neobladder construction for florid cystitis glandularis.

Black PC, Lange PH. Black PC, et al. Urology. 2005 Jan;65(1):174. doi: 10.1016/j.urology.2004.07.026. Urology. 2005. PMID: 15667889

5

Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.

Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW. Wright JL, et al. Among authors: black pc. J Urol. 2007 Dec;178(6):2302-6; discussion 2307. doi: 10.1016/j.juro.2007.08.038. Epub 2007 Oct 15. J Urol. 2007. PMID: 17936803

6

Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.

Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP. Kassouf W, et al. Among authors: black pc. J Urol. 2008 Jan;179(1):353-8. doi: 10.1016/j.juro.2007.08.087. Epub 2007 Nov 19. J Urol. 2008. PMID: 18006009 Free PMC article.

7

Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.

Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP. Black PC, et al. Clin Cancer Res. 2008 Mar 1;14(5):1478-86. doi: 10.1158/1078-0432.CCR-07-1593. Clin Cancer Res. 2008. PMID: 18316572

8

Growth factors and receptors as prognostic markers in urothelial carcinoma.

Black PC, Dinney CP. Black PC, et al. Curr Urol Rep. 2008 Jan;9(1):55-61. doi: 10.1007/s11934-008-0011-6. Curr Urol Rep. 2008. PMID: 18366975 Review.

9

The impact of variant histology on the outcome of bladder cancer treated with curative intent.

Black PC, Brown GA, Dinney CP. Black PC, et al. Urol Oncol. 2009 Jan-Feb;27(1):3-7. doi: 10.1016/j.urolonc.2007.07.010. Epub 2008 Jan 14. Urol Oncol. 2009. PMID: 18367107 Review.

10

Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?

Kassouf W, Brown GA, Black PC, Fisher MB, Inamoto T, Luongo T, Gallagher D, Bar-Eli M, McConkey DJ, Adam L, Dinney CP. Kassouf W, et al. Among authors: black pc. J Urol. 2008 Sep;180(3):1146-53. doi: 10.1016/j.juro.2008.05.001. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters